Earnings ·
Zimmer Biomet Holdings reported second quarter 2026 net sales of $2.177 billion, a 4.8% increase over the prior year…
ZBHZimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings reported second quarter 2026 net sales of $2.177 billion, a 4.8% increase over the prior year period. Diluted earnings per share rose 33.8% to $1.03, while adjusted diluted EPS remained consistent at $2.07. The company generated $447.9 million in operating cash flow and $308.3 million in free cash flow. Management raised full-year 2026 guidance, projecting reported revenue growth of 3.9% to 4.9% and adjusted diluted EPS of $8.47 to $8.59. Additionally, the company announced an increase to share repurchase expectations of up to $1 billion for fiscal year 2026 and named Chintan Desai president of its Asia Pacific Region. Zimmer Biomet operates in the medical technology industry, designing and manufacturing orthopedic products and surgical solutions.